Quaternary ammonium salt derivative containing acetylsalicylic acid cross-linked hydroxypropyl trimethyl chitosan as well as preparation and application of quaternary ammonium salt derivative

By crosslinking chitosan with acetylsalicylic acid, a hydrogel film material with controlled release function was prepared, which solved the adverse reactions caused by excessive local concentration of acetylsalicylic acid and the poor solubility of chitosan. It realizes the stable and slow release of drugs and anti-inflammatory functions, and is suitable for medical materials.

CN118994437APending Publication Date: 2024-11-22YANTAI INST OF COASTAL ZONE RES CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411165545.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Excessive local mass concentration of acetylsalicylic acid can easily lead to adverse reactions, and the solubility of chitosan under neutral and alkaline conditions is poor, making it difficult to directly use as a water-geled biological material, limiting the realization of its controlled release function.

Method used

Hydroxypropyltrimethylchitosan quaternary ammonium salt is generated by reacting chitosan with 2,3-epoxypropyltrimethylchitosan quaternary ammonium salt and crosslinking with epoxypropyl chloride followed by acetylsalicylic acid Blending to prepare a quaternary ammonium derivative of acetylsalicylic acid-containing crosslinked hydroxypropyl trimethyl chitosan to form a hydrogel film material with controlled release function of drug.

Benefits of technology

It improves the biological activity of the material and the slow release function of the drug, reduces the stimulation of the gastrointestinal mucosa, and achieves stable controlled release of the drug. It is suitable for anti-inflammatory medical biological materials, with a simple process and low cost, which is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005007774050000021
    Figure BDA0005007774050000021
  • Figure BDA0005007774050000061
    Figure BDA0005007774050000061
  • Figure BDA0005007774050000071
    Figure BDA0005007774050000071
Patent Text Reader

Abstract

The invention relates to the field of medical biological materials, and provides a hydrogel containing acetylsalicylic acid crosslinked chitosan quaternary ammonium salt as well as a preparation method and application thereof. The preparation method comprises the following steps: firstly, preparing hydroxypropyl trimethyl chitosan quaternary ammonium salt, then taking the hydroxypropyl trimethyl chitosan quaternary ammonium salt as a raw material, carrying out cross-linking reaction on the hydroxypropyl trimethyl chitosan quaternary ammonium salt and epichlorohydrin to prepare cross-linked chitosan quaternary ammonium salt, and then blending the cross-linked chitosan quaternary ammonium salt with acetylsalicylic acid in different molar ratios to obtain the acetylsalicylic acid-containing cross-linked hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative. And finally evaporating water to obtain the acetylsalicylic acid-containing cross-linked hydroxypropyl trimethyl chitosan quaternary ammonium salt hydrogel film. The hydrogel film can effectively control drug release, has good anti-inflammatory activity, can be used as a medical material to be widely applied to the fields of wound dressings, tissue engineering scaffolds, drug controlled release carriers and the like, widens the application value of chitosan-based hydrogel materials, and provides a new thought for development and utilization of marine polysaccharide medical materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the medical material industry, and in particular to a quaternary ammonium salt derivative of acetylsalicylic acid-crosslinked hydroxypropyl trimethyl chitosan and its preparation and application. Background Art

[0002] Acetylsalicylic acid is a commonly used antipyretic and analgesic drug with multiple pharmacological activities such as antipyretic and analgesic, antithrombotic, and anti-inflammatory. It is often used to treat colds, headaches, fever, osteoarthritis, rheumatism, and to prevent and treat angina pectoris, myocardial infarction, etc. However, excessive local mass concentration of acetylsalicylic acid can easily lead to adverse reactions such as nausea, vomiting, upper abdominal discomfort or pain. The use of appropriate drug carriers to achieve controlled release of acetylsalicylic acid can not only give full play to its pharmacological effects, but also help balance blood drug concentrations, reduce the frequency of medication, and reduce irritation to the gastrointestinal mucosa. Therefore, hydrogel controlled-release materials can be developed as a new method of acetylsalicylic acid administration to achieve the purpose of delaying drug release and improving patient medication efficiency.

[0003] Polymer hydrogel refers to a type of three-dimensional polymer network material containing water inside. It generally has good biocompatibility and biosafety and has broad application prospects in wound dressings, drug delivery carriers, tissue engineering scaffolds, etc. Chitosan is a renewable natural polymer polysaccharide. It has a wide range of uses in the field of hydrogel materials due to its good biocompatibility, easy degradation, non-toxicity, and environmental friendliness. However, chitosan has limited biological activity, poor solubility under neutral and alkaline conditions, and its inherent strong hydrogen bonds also make it difficult to be used directly as a hydrogel biomaterial. However, chitosan is rich in hydroxyl and amino groups, providing highly active reaction sites for structural modification. Therefore, bioactive acetylsalicylic acid can be introduced into quaternized chitosan derivatives through chemical modification to improve its water solubility and bioactivity, and can be further prepared into a polymer hydrogel material with specific functions to achieve slow release of acetylsalicylic acid, which is of great significance for the preparation of chitosan-based hydrogel materials with drug controlled release function. Summary of the invention

[0004] The purpose of the present invention is to provide a quaternary ammonium salt derivative of chitosan containing acetylsalicylic acid cross-linked hydroxypropyl trimethyl salt and its preparation and application.

[0005] To achieve the above purpose, the present invention adopts the following technical solution:

[0006] A quaternary ammonium salt derivative of hydroxypropyl trimethyl chitosan cross-linked with acetylsalicylic acid: The chemical structural formula of the quaternary ammonium salt derivative of hydroxypropyl trimethyl chitosan cross-linked with acetylsalicylic acid is:

[0007]

[0008] The average value range of n is 5-12000.

[0009] A method for preparing a cross-linked hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative containing acetylsalicylic acid comprises the following steps: using chitosan as a raw material, reacting it with 2,3-epoxypropyltrimethylammonium chloride to obtain hydroxypropyl trimethyl chitosan quaternary ammonium salt, then using chitosan as a raw material and reacting it with epichlorohydrin to obtain cross-linked chitosan quaternary ammonium salt through a cross-linking reaction, and then blending it with acetylsalicylic acid to obtain the cross-linked hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative containing acetylsalicylic acid.

[0010] Further,

[0011] (1) Preparation of hydroxypropyl trimethyl chitosan quaternary ammonium salt: chitosan is dispersed in isopropanol, stirred at 50-60°C for 2h, then 2,3-epoxypropyl trimethyl ammonium chloride aqueous solution is added thereto, refluxed at 70-80°C, precipitated with anhydrous ethanol after the reaction, and freeze-dried to obtain chitosan quaternary ammonium salt;

[0012] (2) Preparation of cross-linked chitosan quaternary ammonium salt gel solution: disperse chitosan quaternary ammonium salt in deionized water, stir evenly to obtain a colorless transparent solution, then adjust the pH of the colorless transparent solution to alkaline, then add epichlorohydrin, and continue stirring at 70°C, and maintain the pH of the reaction system to be alkaline. After reacting for 4 hours, adjust the pH of the reaction system to neutral, and dialyze with deionized water to obtain a slightly yellowish transparent cross-linked chitosan quaternary ammonium salt gel solution;

[0013] (3) Preparation of hydroxypropyl trimethyl chitosan quaternary ammonium salt derivatives cross-linked with acetylsalicylic acid: Add acetylsalicylic acid salt solution to the dialyzed gel solution, and blend to obtain hydroxypropyl trimethyl chitosan quaternary ammonium salt derivatives cross-linked with acetylsalicylic acid.

[0014] In the step (1), the amount of isopropanol used is 25 mL per 1 g of chitosan, the molar ratio of 2,3-epoxypropyltrimethylammonium chloride to chitosan is (2-4):1, and the amount of anhydrous ethanol used is 150 mL per 1 g of chitosan.

[0015] In the step (2), the amount of deionized water used is 100 mL per 1 g of chitosan quaternary ammonium salt, the amount of epichlorohydrin used is 1-3 mL per 1 g of chitosan quaternary ammonium salt, sodium hydroxide is used to adjust the pH of the system to alkaline, and hydrochloric acid is used to adjust the pH of the system to neutral, and the volume concentrations of the sodium hydroxide solution and the hydrochloric acid solution are both 10%.

[0016] In the step (3), the molar ratio of the chitosan quaternary ammonium salt to the acetylsalicylic acid anion is 1:(1.25-1.5).

[0017] The dialysis operation in step (2) is as follows: add the solution into a dialysis bag with a molecular weight cutoff of 10,000, ensure that the dialysis bag is well sealed, and then suspend it in a beaker filled with deionized water, stir and dialyze for 48 hours to remove the residual reaction reagents, and complete the dialysis.

[0018] In the step (3), acetylsalicylic acid salt solution is added to the dialyzed gel solution, and glycerol is poured into the gel solution, and stirred at 70° C. for 12 hours to obtain a chitosan quaternary ammonium salt water gel containing acetylsalicylic acid cross-linking; the amount of glycerol used is 0.1-0.2 mL per 1 g of chitosan quaternary ammonium salt.

[0019] An application of the quaternary ammonium salt derivative of chitosan cross-linked with acetylsalicylic acid and hydroxypropyl trimethyl salt, and an application of the quaternary ammonium salt derivative of chitosan cross-linked with acetylsalicylic acid as an anti-inflammatory medical biomaterial.

[0020] As a biomaterial, the obtained quaternary ammonium salt of hydroxypropyl trimethyl chitosan cross-linked with acetylsalicylic acid was poured into a disposable plastic surface dish and dried in a constant temperature drying oven at 40° C. for 24 hours to finally form a hydrogel film.

[0021] Compared with the prior art, the present invention has the following beneficial technical features:

[0022] (1) The acetylsalicylic acid cross-linked hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative prepared by the present invention has the advantages of chitosan quaternary ammonium salt biocompatibility and degradability, and the presence of acetylsalicylic acid active molecules also improves its biological activity;

[0023] (2) In the hydrogel film containing acetylsalicylic acid cross-linked hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative prepared by the present invention, the ionic bond between the transport carrier and the active drug can stabilize the acetylsalicylic acid molecules, prevent their aggregation, and effectively exert their slow release function;

[0024] (3) The method for preparing the hydrogel film material of the present invention has a simple process, the required equipment and raw materials are easily available, the cost is low, and it is convenient for industrial production. It can be used to prepare medical dressings, biological scaffolds and drug sustained-release carriers. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 is the H-NMR spectrum of chitosan;

[0026] Figure 2 This is the H NMR spectrum of the hydroxypropyl trimethyl chitosan quaternary ammonium salt prepared in Example 1 of the present invention;

[0027] Figure 3 This is the H NMR spectrum of the quaternary ammonium salt of chitosan cross-linked with acetylsalicylic acid prepared in Example 2 of the present invention;

[0028] Figure 4 This is a scanning electron microscope image of the cross-section of the quaternary ammonium salt water gel film containing acetylsalicylic acid cross-linked chitosan prepared in Example 3 of the present invention. DETAILED DESCRIPTION

[0029] The present invention is described in detail below with reference to the embodiments, but the protection scope of the present invention is not limited by the embodiments.

[0030] The invention uses hydroxypropyl trimethyl chitosan quaternary ammonium salt as a reaction intermediate, prepares a cross-linked chitosan quaternary ammonium salt gel solution by chemical cross-linking, and further prepares the cross-linked chitosan quaternary ammonium salt gel solution into a hydrogel film material with acetylsalicylic acid sustained-release performance by an ion exchange method, thus broadening the way for the application of chitosan and its derivatives in the field of medical materials, and also providing a theoretical reference for the preparation of a hydrogel material with a drug sustained-release function.

[0031] Embodiment 1:

[0032] (1) Preparation of hydroxypropyl trimethyl chitosan quaternary ammonium salt: weigh 1.61 g of chitosan and disperse it in 40 mL of isopropanol, stir at 50° C. for 2 h, weigh 3.02 g of 2,3-epoxypropyl trimethyl ammonium chloride and dissolve it in deionized water, and slowly add it to the chitosan isopropanol solution, reflux at 70° C. for 10 h, pour it into excess ethanol after the reaction, and freeze-dry the resulting precipitate to obtain hydroxypropyl trimethyl chitosan quaternary ammonium salt;

[0033] (2) Preparation of cross-linked chitosan quaternary ammonium salt gel solution: Weigh 2g of hydroxypropyl trimethyl chitosan quaternary ammonium salt and 100mL of deionized water, add them into a 250mL two-necked flask, place it in a water bath thermostat magnetic stirrer and stir evenly at 60°C to obtain a colorless and transparent solution. First, adjust the pH of the solution to 10 with sodium hydroxide solution, then add 2mL of epichlorohydrin, and continue to stir at 60°C. During the reaction, continuously add sodium hydroxide solution to maintain the pH value of the reaction system at about 10. After reacting for 4 hours, add an appropriate amount of hydrochloric acid solution to adjust the pH of the reaction system to 7 to obtain a translucent cross-linked chitosan quaternary ammonium salt, then add it to a dialysis bag with a molecular weight cutoff of 10,000, and dialyze in a deionized water environment for 48 hours to obtain a slightly yellowish and transparent cross-linked chitosan quaternary ammonium salt gel solution;

[0034] (3) Preparation of acetylsalicylic acid cross-linked hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative: The dialyzed gel solution was poured into a beaker, and acetylsalicylic acid salt solutions of different molar ratios were added (the molar ratio of chitosan quaternary ammonium salt to acetylsalicylic acid anion in sample 1 was 1:0.75; sample 2 was 1:1; sample 3 was 1:1.25; sample 4 was 1:1.5; sample 5 was 1:1.75; sample 6 was 1:2, and different amounts were used as controls, i.e., the controls were samples 1, 2, 5 and 6), and 0.4 mL of glycerol was poured into the gel solution to improve the film-forming property and hygroscopicity of the film. The beaker was then placed in a heat-collecting constant temperature heating magnetic stirrer and stirred at 70°C for 12 h. After the liquid level in the beaker dropped to 40 mL, the gel solution was poured into a disposable plastic surface dish and dried in a constant temperature drying oven at 40° C. for 24 h to finally obtain a transparent quaternary ammonium salt gel film containing acetylsalicylic acid cross-linked chitosan.

[0035] Figure 1 This is the H NMR spectrum of chitosan. The chemical shift of polysaccharide skeleton hydrogen in the chitosan molecule is mainly distributed between δ3.0-5.5ppm, among which the signal peaks at δ5.5ppm, δ3.6-3.9ppm and δ3.0ppm belong to the chemical shifts of [H1], [H3]-[H6] and [H2] respectively.

[0036] Figure 2 This is the H NMR spectrum of the hydroxypropyl trimethyl chitosan quaternary ammonium salt prepared in Example 1 of the present invention. After chitosan reacts with 2,3-epoxypropyl trimethyl ammonium chloride, the H NMR spectrum of the product shows chemical shifts of methylene and methine at δ4.2ppm, δ2.8ppm, and δ2.6ppm, and -N + The characteristic absorption peak of hydrogen proton on (CH3)3 indicated that the quaternary ammonium salt of hydroxypropyl trimethyl chitosan was successfully prepared.

[0037] Embodiment 2:

[0038] (1) Preparation of hydroxypropyl trimethyl chitosan quaternary ammonium salt: weigh 1.61 g of chitosan and disperse it in 40 mL of isopropanol, stir at 55° C. for 2 h, weigh 4.53 g of 2,3-epoxypropyl trimethyl ammonium chloride and dissolve it in deionized water, and slowly add it to the chitosan isopropanol solution, reflux at 75° C. for 10 h, pour it into excess ethanol after the reaction, and freeze-dry the resulting precipitate to obtain hydroxypropyl trimethyl chitosan quaternary ammonium salt;

[0039] (2) Preparation of cross-linked chitosan quaternary ammonium salt gel solution: Weigh 2g of hydroxypropyl trimethyl chitosan quaternary ammonium salt and 100mL of deionized water, add them into a 250mL two-necked flask, place it in a water bath thermostat magnetic stirrer and stir evenly at 70°C to obtain a colorless and transparent solution. First, adjust the pH of the solution to 10 with sodium hydroxide solution, then add 4mL of epichlorohydrin, and continue to stir at 70°C. During the reaction, continuously add sodium hydroxide solution to maintain the pH value of the reaction system at about 10. After reacting for 4 hours, add an appropriate amount of hydrochloric acid solution to adjust the pH of the reaction system to 7 to obtain a translucent cross-linked chitosan quaternary ammonium salt, then add it to a dialysis bag with a molecular weight cutoff of 10,000, and dialyze in a deionized water environment for 48 hours to obtain a slightly yellowish and transparent cross-linked chitosan quaternary ammonium salt gel solution;

[0040] (3) Preparation of hydrogel film containing quaternary ammonium salt of chitosan cross-linked with acetylsalicylic acid: Pour the dialyzed gel solution into a beaker, add acetylsalicylic acid salt solution of different molar ratios (the molar ratio of chitosan quaternary ammonium salt to acetylsalicylic acid anion in sample 1 is 1:0.75; sample 2 is 1:1; sample 3 is 1:1.25; sample 4 is 1:1.5; sample 5 is 1:1.75; sample 6 is 1:2, and different amounts are used as controls, i.e., the controls are samples 1, 2, 5 and 6), and measure 0.2 mL of glycerol and pour it into the gel solution, then place the beaker in a heat-collecting constant temperature heating magnetic stirrer at 70°C and stir for 12 hours. After the liquid level in the beaker is reduced to 40 mL, pour the gel solution into a disposable plastic watch glass and dry it in a constant temperature drying oven at 40°C for 24 hours to finally obtain a transparent hydrogel film containing quaternary ammonium salt of chitosan cross-linked with acetylsalicylic acid.

[0041] Figure 3 The H NMR spectrum of the quaternary ammonium salt of chitosan cross-linked with acetylsalicylic acid prepared in Example 2 of the present invention is as follows: Figure 3 It can be seen that all derivatives show chemical shift of proton hydrogen on the benzene ring of acetylsalicylic acid in the low field region (δ6.8-7.7ppm), a signal peak of hydrogen proton on the methyl group of acetylsalicylic acid appears at around δ3.0ppm, and a new proton peak appears at around δ3.4ppm, which corresponds to the methylene and methine proton peaks (HA, HB, HC) on the cross-linking point (-CH2CH(OH)CH2-). In addition, the chemical shift of hydrogen proton of quaternary ammonium salt group still exists. The above shows that cross-linked chitosan quaternary ammonium salt derivatives containing acetylsalicylic acid are successfully prepared.

[0042] Embodiment 3:

[0043] (1) Preparation of hydroxypropyl trimethyl chitosan quaternary ammonium salt: weigh 1.61 g of chitosan and disperse it in 40 mL of isopropanol, stir at 60° C. for 2 h, weigh 6.04 g of 2,3-epoxypropyl trimethyl ammonium chloride and dissolve it in deionized water, and slowly add it to the chitosan isopropanol solution, reflux at 80° C. for 10 h, pour it into excess ethanol after the reaction, and freeze-dry the resulting precipitate to obtain hydroxypropyl trimethyl chitosan quaternary ammonium salt;

[0044] (2) Preparation of cross-linked chitosan quaternary ammonium salt gel solution: Weigh 2g of hydroxypropyl trimethyl chitosan quaternary ammonium salt and 100mL of deionized water, add them into a 250mL two-necked flask, place it in a water bath thermostat magnetic stirrer and stir evenly at 80°C to obtain a colorless and transparent solution. First, adjust the pH of the solution to 10 with sodium hydroxide solution, then add 6mL of epichlorohydrin, and continue to stir at 80°C. During the reaction, continuously add sodium hydroxide solution to maintain the pH value of the reaction system at about 10. After reacting for 4 hours, add an appropriate amount of hydrochloric acid solution to adjust the pH of the reaction system to 7 to obtain a translucent cross-linked chitosan quaternary ammonium salt, then add it to a dialysis bag with a molecular weight cutoff of 10,000, and dialyze in a deionized water environment for 48 hours to obtain a slightly yellowish and transparent cross-linked chitosan quaternary ammonium salt gel solution;

[0045] (3) Preparation of hydrogel film containing quaternary ammonium salt of chitosan cross-linked with acetylsalicylic acid: Pour the dialyzed gel solution into a beaker, add acetylsalicylic acid salt solution of different molar ratios (the molar ratio of chitosan quaternary ammonium salt to acetylsalicylic acid anion in sample 1 is 1:0.75; sample 2 is 1:1; sample 3 is 1:1.25; sample 4 is 1:1.5; sample 5 is 1:1.75; sample 6 is 1:2, and different amounts are used as controls, i.e., the controls are samples 1, 2, 5 and 6), and measure 0.4 mL of glycerol and pour it into the gel solution, then place the beaker in a heat-collecting constant temperature heating magnetic stirrer at 70°C and stir for 12 hours. After the liquid level in the beaker is reduced to 40 mL, pour the gel solution into a disposable plastic watch glass and dry it in a constant temperature drying oven at 40°C for 24 hours to finally obtain a transparent hydrogel film containing quaternary ammonium salt of chitosan cross-linked with acetylsalicylic acid.

[0046] Figure 4 This is a scanning electron microscope image of a cross-section of a quaternary ammonium salt water gel film containing acetylsalicylic acid cross-linked chitosan prepared in Example 3 of the present invention. Figure 4 It can be seen that the interior of the hydrogel film is dense and uniform before water absorption, without any holes. In contrast, after water absorption, a large number of holes appeared in the cross-section of the quaternary ammonium salt hydrogel film containing acetylsalicylic acid cross-linked chitosan, and the interior of the hydrogel showed a loose network structure, which further proved the successful preparation of the hydrogel film.

[0047] Determination of acetylsalicylic acid release performance

[0048] (1) Standard curve determination: Prepare sodium acetylsalicylate standard solutions with mass concentrations of 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 mg / L, respectively, and measure the absorbance of each standard solution at an absorption wavelength of 300 nm using a UV-visible spectrophotometer. Draw a standard working curve (y=2.37586x+0.12748, R2=0.99306) with the concentration of the acetylsalicylic acid standard solution as the abscissa and the absorbance as the ordinate.

[0049] (2) Determination of drug release rate: The in vitro sustained release performance of the hydrogel film in Example 2 under the condition of pH=7.4 was determined using a drug dissolution instrument and an ultraviolet spectrophotometer. During the experiment, 500 mL of PBS buffer solution was used as a dissolution medium to simulate the in vivo environment. A quarter of a hydrogel film containing acetylsalicylic acid cross-linked chitosan quaternary ammonium salt prepared in Example 2 (i.e., the sample of the present invention and the control sample) was weighed and placed in a dialysis tube (molecular weight cutoff of 10,000) containing 20 mL of PBS buffer solution. Then, the dialysis tube was placed in a drug dissolution instrument containing 480 mL of PBS buffer solution and dialyzed at 37°C at a speed of 100 rpm. Finally, 20 mL of the dissolution medium was taken at predetermined time intervals (2, 4, 6, 8, 10, 12, 24 and 48 h), and the amount of acetylsalicylic acid released was determined by an ultraviolet spectrophotometer at a wavelength of 300 nm, and an equal amount of PBS buffer was immediately supplemented. The cumulative release of acetylsalicylic acid at each sampling time point was divided by its initial weight to calculate the release rate. The results are shown in Table 1.

[0050] Table 1 In vitro drug release rate of quaternary ammonium salt hydrogel film samples containing acetylsalicylic acid cross-linked chitosan in different proportions (%)

[0051]

[0052] The experimental results show that acetylsalicylic acid alone has a burst release phenomenon in the first 2 hours, and the cumulative release rate can reach 87.87%, almost reaching the maximum drug release. Compared with acetylsalicylic acid alone, the cross-linked hydrogel film material has a significant sustained release effect. The release amount in the first two hours is relatively small, and it tends to be stable until 12 hours. Overall, their release behavior can be divided into an initial rapid release stage and a plateau sustained release stage. The rapid release phenomenon is mainly caused by two aspects: on the one hand, when the hydrogel material is combined with the buffer, due to the large concentration difference, some of the drugs adsorbed on the surface of the hydrogel will fall off from the surface in a short time; on the other hand, when the prepared hydrogel film is in contact with water, the hydrogen bonds formed in the surface area accelerate the free diffusion of acetylsalicylic acid. In the sustained release stage, the drug is embedded in the hydrogel, and there is an electrostatic attraction in it. It takes a long time for acetylsalicylic acid to be released in the medium through the gel layer. Of course, hydrogel films with different acetylsalicylic acid contents show different drug sustained release capabilities. Since the content of acetylsalicylic acid in sample 1 is relatively low, it is mainly combined with the chitosan quaternary ammonium salt carrier in an ionic bond mode. When it tends to be stable, its cumulative release amount is relatively low, only 40%. The content of acetylsalicylic acid in samples 5 and 6 is relatively high, there is a certain burst release behavior, and the sustained release time is only 6-8h, so it is not an ideal choice for drug sustained release materials. Samples 2, 3 and 4 can achieve the effect of slow release of drugs between 2-12h, and their cumulative release rate can reach more than 50% when the drug release is stable, which has the advantages of controlling drug release and prolonging drug action time, and has broad application prospects in the field of drug controlled release materials.

[0053] Anti-inflammatory activity assay

[0054] Cell culture: Take out the frozen RAW 264.7 cell line and quickly transfer it to a 37°C water bath for recovery. Add it to complete culture medium containing fetal bovine serum and culture it in a carbon dioxide incubator until it adheres to the wall.

[0055] Sample preparation: Weigh 2.5 mg of cross-linked chitosan quaternary ammonium salt gel containing different acetylsalicylic acid, soak it in 5 mL of complete cell culture medium, and take the extract after soaking for 24 hours to culture RAW264.7 cells, and use the MTT method for cytotoxicity test.

[0056] (1) Cytotoxicity assay: Take RAW264.7 cells in the logarithmic growth phase, adjust the cell concentration to 1×105 cells / mL, and inoculate them in a 96-well plate. Place it in a carbon dioxide incubator at a temperature of 37°C, a CO2 volume fraction of 5%, and saturated humidity for 24 hours to allow the cells to adhere to the wall. Add samples of different concentrations to the culture plate, set 3-5 replicate wells for each sample and each concentration, and continue to culture for 24 hours. Aspirate the culture medium, add 100 μL of MTT solution to each well, continue to culture for 4 hours, then add 150 μL of stop solution to each well, and measure the absorbance at 490 nm using an enzyme-linked immunosorbent assay. The cell viability calculation formula is as follows:

[0057] Cell survival rate (%) = (ODa) / ODb) × 100

[0058] Wherein, ODa is the OD value of the blank control group at 490nm; ODb is the OD value of the experimental group at 490nm. The results are shown in Table 2.

[0059] Table 2 Cytotoxicity of quaternary ammonium salt hydrogel films containing acetylsalicylic acid cross-linked chitosan to RAW264.7 cells

[0060]

[0061] (2) Determination of nitric oxide content: Take RAW 264.7 cells in the logarithmic growth phase, adjust the cell concentration to 1×105 / mL, inoculate them in a 96-well plate, and place them in a carbon dioxide incubator at a temperature of 37°C, a CO2 volume fraction of 5%, and a saturated humidity for 24 hours. Then, aspirate and discard the culture medium, add complete culture medium containing the sample to be tested and LPS, and set complete culture medium as a blank control and complete culture medium containing only LPS as a positive control, and set 3-5 replicate wells for each. After continuing to culture for 24 hours, take 80 μL of supernatant from each well to a new 96-well plate, add an equal volume of Griess reagent, place at room temperature and away from light for 10 minutes, use an enzyme-linked immunosorbent assay to measure the absorbance at 540 nm, and substitute it into the standard curve (y=0.00909x+0.05185, R2=0.99997) to calculate the expression of nitric oxide. Finally, the percentage of NO released in each sample was calculated with the nitric oxide concentration in the positive control as 100%. The results are shown in Table 3.

[0062] Table 3 Acetylsalicylic acid cross-linked chitosan quaternary ammonium salt hydrogel film down-regulates LPS-induced nitric oxide expression in RAW 264.7 cells (%)

[0063]

[0064] After RAW 264.7 cells were treated with the hydrogel film extract containing acetylsalicylic acid cross-linked chitosan quaternary ammonium salt water for 24 hours, the survival rate is shown in Table 2. At the tested concentration, the survival rate of cells treated with the hydrogel film extract was more than 80%, indicating that the hydrogel film containing acetylsalicylic acid cross-linked chitosan quaternary ammonium salt water had no cytotoxicity to RAW 264.7 cells.

[0065] Table 3 shows the percentage of NO released by LPS-induced RAW 264.7 cells after co-culture with different hydrogel film extracts for 24 hours. As can be seen from the figure, compared with the positive control group, the chitosan quaternary ammonium salt hydrogel film material containing acetylsalicylic acid can significantly reduce the NO release, and it increases with the increase of acetylsalicylic acid content, which fully demonstrates that the presence of acetylsalicylic acid has a positive effect on improving the anti-inflammatory activity of chitosan-based hydrogel materials. Among them, the inhibition rate of hydrogel samples 1 and 2 on NO release is only about 45%, which cannot achieve the anti-inflammatory effect of hydrogel in medical applications, so there is no value in medical material utilization; under the same conditions, hydrogel samples 3, 4, 5 and 6 can inhibit more than 60% of NO, showing more excellent anti-inflammatory activity, which can effectively exert anti-inflammatory therapeutic effects and have more medical prospects.

[0066] The comprehensive drug sustained release test results were used to further analyze the hydrogel samples 3, 4, 5 and 6. It was found that although the inhibition rate of NO in samples 5 and 6 was as high as 70%, there was an obvious drug burst after 2 hours of administration, and the sustained release effect of acetylsalicylic acid was poor. However, under the same test conditions, samples 3 and 4 could not only inhibit NO by more than 60%, but also had the advantages of controlling drug release and prolonging drug action time. Therefore, samples 3 and 4, that is, when the ratio of chitosan quaternary ammonium salt to acetylsalicylic acid was 1:1.25 to 1:1.5, the physicochemical properties of the hydrogel film were optimal and had the most application prospects in the field of medical materials.

Claims

1. A quaternary ammonium salt derivative of chitosan cross-linked with acetylsalicylic acid, characterized in that: The chemical structure of the quaternary ammonium salt derivative of hydroxypropyl trimethyl chitosan cross-linked with acetylsalicylic acid is: The average value range of n is 5-12000.

2. A method for preparing the quaternary ammonium salt derivative of acetylsalicylic acid cross-linked hydroxypropyl trimethyl chitosan according to claim 1, characterized in that: Chitosan is used as a raw material, and is reacted with 2,3-epoxypropyltrimethylammonium chloride to obtain hydroxypropyltrimethyl chitosan quaternary ammonium salt, which is then used as a raw material to react with epichlorohydrin to obtain a cross-linked chitosan quaternary ammonium salt, which is then mixed with acetylsalicylic acid to obtain a cross-linked hydroxypropyltrimethyl chitosan quaternary ammonium salt derivative containing acetylsalicylic acid.

3. The preparation method according to claim 2, characterized in that: (1) Preparation of hydroxypropyl trimethyl chitosan quaternary ammonium salt: chitosan is dispersed in isopropanol, stirred at 50-60°C for 2h, then 2,3-epoxypropyl trimethyl ammonium chloride aqueous solution is added thereto, refluxed at 70-80°C, precipitated with anhydrous ethanol after the reaction, and freeze-dried to obtain chitosan quaternary ammonium salt; (2) Preparation of cross-linked chitosan quaternary ammonium salt gel solution: disperse chitosan quaternary ammonium salt in deionized water, stir evenly to obtain a colorless transparent solution, then adjust the pH of the colorless transparent solution to alkaline, then add epichlorohydrin, and continue stirring at 70°C, and maintain the pH of the reaction system to be alkaline. After reacting for 4 hours, adjust the pH of the reaction system to neutral, and dialyze with deionized water to obtain a slightly yellowish transparent cross-linked chitosan quaternary ammonium salt gel solution; (3) Preparation of chitosan quaternary ammonium salt water gel containing acetylsalicylic acid cross-linking: acetylsalicylic acid salt solution is added to the dialyzed gel solution, and the mixture is blended to obtain hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative containing acetylsalicylic acid cross-linking.

4. The preparation method according to claim 3, characterized in that: In the step (1), the amount of isopropanol used is 25 mL per 1 g of chitosan, the molar ratio of 2,3-epoxypropyltrimethylammonium chloride to chitosan is (2-4):1, and the amount of anhydrous ethanol used is 150 mL per 1 g of chitosan.

5. The preparation method according to claim 3, characterized in that: In the step (2), the amount of deionized water used is 100 mL per 1 g of chitosan quaternary ammonium salt, the amount of epichlorohydrin used is 1-3 mL per 1 g of chitosan quaternary ammonium salt, sodium hydroxide is used to adjust the pH of the system to alkaline, and hydrochloric acid is used to adjust the pH of the system to neutral, and the volume concentrations of the sodium hydroxide solution and the hydrochloric acid solution are both 10%.

6. The preparation method according to claim 3, characterized in that: In the step (3), the molar ratio of the chitosan quaternary ammonium salt to the acetylsalicylic acid anion is 1:(1.25-1.5).

7. The preparation method according to claim 3, characterized in that: The dialysis operation in step (2) is as follows: add the solution into a dialysis bag with a molecular weight cutoff of 10,000, ensure that the dialysis bag is well sealed, and then suspend it in a beaker filled with deionized water, stir and dialyze for 48 hours to remove the residual reaction reagents, and complete the dialysis.

8. The preparation method according to claim 2 or 3, characterized in that: In the step (3), acetylsalicylic acid salt solution is added to the dialyzed gel solution, and glycerol is poured into the gel solution, and stirred at 70° C. for 12 hours to obtain a chitosan quaternary ammonium salt water gel containing acetylsalicylic acid cross-linking; the amount of glycerol used is 0.1-0.2 mL per 1 g of chitosan quaternary ammonium salt.

9. An application of the quaternary ammonium salt derivative of acetylsalicylic acid cross-linked hydroxypropyl trimethyl chitosan according to claim 1, characterized in that: The invention discloses an application of the acetylsalicylic acid-crosslinked hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative as an anti-inflammatory medical biomaterial.